logo BDSP

Base documentaire


Fermeture du portail BDSP le 1er juillet 2019. En savoir plus...

  1. Lipid-lowering medication and risk of cancer.

    Article - En anglais

    Low or declining levels of serum cholesterol have been associated with increased mortality from cancer.

    We conducted a population-based cohort study of 1882 patients from one Danish county who received lipid-lowering drugs between january 1,1991 and December 31,1994.

    During the follow-up period of up to 4 years, 41 cancers were observed among user of lipid-lowering drugs, with 42.9 expected, to yield an age-and sex-standardized incidence ratio of 1.0 (95% confidence interval, 0.7-1.3).

    Although limited hy small numbers and short follow-up period, examination by site of cancer and type of drug provided no evidence of an association.

    Further research is needed, however, with longer follow-up to assess more fully any potential cancer risk with these medications.

    Mots-clés Pascal : Tumeur maligne, Hypolipémiant, Epidémiologie, Toxicité, Homme, Etude cohorte, Pharmacovigilance

    Mots-clés Pascal anglais : Malignant tumor, Antilipemic agent, Epidemiology, Toxicity, Human, Cohort study, Pharmacovigilance

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0175804

    Code Inist : 002B02U10. Création : 16/11/1999.



Fermeture du portail BDSP le 1er juillet 2019

Nous avons le regret de vous informer de la fermeture du portail BDSP le 1er juillet 2019. Du 1er janvier au 30 juin 2019, le site et ses services resteront accessibles mais ne seront plus alimentés, ni mis à jour. En savoir plus...